Facilitating NHS adoption of ATMPs

CGT Catapult coordinates the Advanced Therapy Treatment Centres (ATTC), a network of facilities addressing the unique and complex challenges of accelerating the adoption of advanced therapy medicinal products (ATMPs) into the NHS.

The ATTC network programme is a world first, operating within the NHS framework to develop systems and procedures to introduce ATMPs into the clinic and establishing them as a standard of care.

The ATTCs are spread across the UK:

Innovate Manchester Advanced Therapy Centre Hub (iMATCH): Comprising Greater Manchester Trusts and Sheffield
London Advanced Therapies Advanced Therapy Treatment Centre (LAT-ATTC): Comprising Imperial College London, King’s College London, Queen Mary University of London, University College London, and their NHS Trusts
Midlands-Wales Advanced Therapy Treatment Centre (MW-ATTC): Comprising Birmingham, Cardiff, Leicester, Nottingham, and Swansea
Northern Alliance Advanced Therapies Treatment Centre (NA-ATTC): Comprising Edinburgh, Glasgow, Leeds, Sheffield and Newcastle

Working on a cell or gene therapy innovation challenge?

Contact